Resveratrol inhibition of lipid peroxidation

References

• Langcake P., Pryce R.J. The production of resveratrol by Vitis vinifera and other members of the Vitaceae as a response to infection and injury. Physiology and Plant Pathology 1976; 9: 77–86
   Web of Science ®Google Scholar
• Clement M.V., Hirpara J.L., Chawdhury S.H., Pervaiz S. Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood 1998; 92: 996–1002
   PubMed Web of Science ®Google Scholar
• Huang C., Ma W.Y., Goranson A., Dong Z. Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway. Carcinogenesis 1999; 20: 237–242
   PubMed Web of Science ®Google Scholar
• Della Ragione F., Cucciolla V., Borriello A., Della Pietra V., Racioppi L., Soldati G., Manna C., Galletti P., Zappia V. Resveratrol arrests the cell division cycle at S/G2 phase transition. Biochemical and Biophysical Research Communications 1998; 250: 53–58
   PubMedGoogle Scholar
• Subbaramaiah K., Chung W.J., Michaluart P., Telang N., Tanabe T., Inoue H., Jang M., Pezzuto J.M., Dannenberg A.J. Resveratrol inhibits cyclooxygenase-2-transcription and activity in phorbol ester-treated human mammary epithelial cells. Journal of Biological Chemistry 1998; 273: 21875–21882
   PubMed Web of Science ®Google Scholar
• Kimura Y., Okuda H., Kubo M. Effects of stilbenes isolated from medicinal plants on arachidonate metabolism and degranulation in human polymorphonuclear leukocytes. Journal of Ethnopharmacology 1995; 45: 131–139
   PubMed Web of Science ®Google Scholar
• Pace-Asciak C.R., Haln S., Diamandis E.P., Soleas G., Goldberg D.M. The red wine phenolics transresveratrol and quercitin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease. Clinica Chimica Acta 1995; 235: 207–219
   PubMed Web of Science ®Google Scholar
• Jang M., Cai L., Udeani G.O., Slowing K.V., Thomas C.F., Beecher C.W., Fong H.H., Farnsworth N.R., Kinghorn A.D., Mehta R.G., Moon R.C., Pezzuto J.M. Cancer chemoprotective activity of resveratrol, a natural product derived from grapes. Science 1997; 275: 218–220
   PubMed Web of Science ®Google Scholar
• Jang D.S., Kang B.S., Ryu S.Y., Chang I.M., Min K.R., Kim Y. Inhibitory effects of resveratrol analogs on unopsonized zymosan-induced oxygen radical production. Biochemical Pharmacology 1999; 57: 705–712
   PubMed Web of Science ®Google Scholar
• Chung M.I., Teng C.M., Cheng K.L., Ko F.N., Lin C.N. An antiplatelet principle of Veratrum formosarum. Planta Medica 1992; 58: 274–276
   PubMed Web of Science ®Google Scholar
• Siemann E.H., Creasy L.L. Concentration of the phytoalexin resveratrol in wine. American Journal of Enology and Viticulture 1992; 43: 49–52
   Web of Science ®Google Scholar
• Frankel E.N., Kanner J., German J.B., Parks E., Kinsella J.E. Inhibition of oxidation of human-low density lipoprotein by phenolic substances in red wine. Lancet 1993; 341: 454–457
   PubMed Web of Science ®Google Scholar
• Frankel E.N., Waterhouse A.L., Kinsella J.E. Inhibition of human LDL oxidation by resveratrol. Lancet 1993; 341: 1103–1104
   PubMed Web of Science ®Google Scholar
• Constant J. Alcohol, ischemic heart disease, and the French paradox. Coronary Artery Disease 1997; 8: 645–649
   PubMed Web of Science ®Google Scholar
• Belguendouz L., Fremont L., Linard A. Resveratrol inhibits metal ion-dependent and independent peroxidation of porcine low-density lipoproteins. Biochemical Pharmacology 1997; 53: 1347–1355
   PubMed Web of Science ®Google Scholar
• Belguendouz L., Fremont L., Gozzelino M.T. Interaction of transresveratrol with plasma lipoproteins. Biochemical Pharmacology 1998; 55: 811–816
   PubMed Web of Science ®Google Scholar
• Wilson T., Knight T.J., Beitz D.C., Lewis D.S., Engen R.L. Resveratrol promotes atherosclerosis in hypercholesterolemic rabbits. Life Sciences 1996; 59: 15–21
   PubMedGoogle Scholar
• Turrens J.F., Lariccia J., Nair M.G. Resveratrol has no effect on lipoprotein profile and does not prevent peroxidation of serum lipids in normal rats. Free Radical Research 1997; 27: 557–562
   PubMed Web of Science ®Google Scholar
• Griendling K.K., Ushio-Fukai M. Redox control of vascular smooth muscle proliferation. Journal of Laboratory and Clinical Medicine 1998; 132: 9–15
   PubMed Web of Science ®Google Scholar
• Hampton M.B., Orrenius S. Redox regulation of apoptosis cell death in the immune system. Toxicology Letters 1998; 102–103: 355–358
   PubMedGoogle Scholar
• Green D.R., Reed J.C. Mitochondria and apoptosis. Science 1998; 281: 1309–1312
   PubMed Web of Science ®Google Scholar
• Tadolini B., Fiorentini D., Landi L., Cabrini L. Lipid peroxidation. Definition of experimental conditions for selective study of the propagation and termination phases. Free Radical Research Communications 1989; 5: 245–252
   PubMedGoogle Scholar
• Tadolini B., Hakim G. The mechanism of iron(III) stimulation of lipid peroxidation. Free Radical Research 1996; 25: 221–227
   PubMed Web of Science ®Google Scholar
• Tadolini B., Cabrini L., Menna C., Pinna G.G., Hakim G. Iron(III) stimulation of lipid hydroperoxide-dependent lipid peroxidation. Free Radical Research 1997; 27: 563–576
   PubMed Web of Science ®Google Scholar
• Hope M.J., Bally M.B., Webb G., Cullis P.R. Production of large unilamellar vesicles by a rapid extrusion procedure. Characterization of size distribution, trapped volume and ability to maintain a membrane potential. Biochimica and Biophysica Acta 1985; 812: 55–65
   PubMed Web of Science ®Google Scholar
• Landi L., Fiorentini D., Stefanelli C., Pasquali P., Pedulli G.F. Inhibition of autoxidation of egg yolk phosphatidylcholine in homogeneous solution and in liposomes by oxidized ubiquinone. Biochimica and Biophysica Acta 1990; 1028: 223–228
   PubMed Web of Science ®Google Scholar
• Marinetti G.V. Chromatographic separation, identification and analysis of phosphatides. Journal of Lipid Research 1962; 3: 1–20
   Web of Science ®Google Scholar
• Mahler H.R., Elowe D.G. Studies on metallo-flavoproteins. II The role of iron in diphosphopyridine nucleotide cytochrome c reductase. Journal of Biological Chemistry 1954; 210: 165–179
   PubMed Web of Science ®Google Scholar
• Klein R.A. The detection of oxidation in liposome preparations. Biochimica and Biophysica Acta 1970; 210: 468–489
   Google Scholar
• Joyeux M., Lobstein A., Anton R., Mortier F. Comparative antilipoperoxidant, antinecrotic and scavenging properties of terpenes and biflavones from Ginko and some flavonoids. Planta Medica 1995; 61: 126–129
   PubMed Web of Science ®Google Scholar
• Brand-Williams W., Cuvelier M.E., Berset C. Use of a free radical method to evaluate antioxidant activity. Lebensmittel Wissenschaft und Technologie 1995; 28: 25–30
   Web of Science ®Google Scholar
• Driomina E.S., Sharov V.S., Vladimirov Y.A. Fe2+-induced lipid peroxidation kinetics in liposomes: the role of surface Fe2+ concentration in switching the reaction from acceleration to decay. Free Radical Biology and Medicine 1993; 15: 239–247
   PubMed Web of Science ®Google Scholar
• Minotti G., Aust S.D. The requirement of iron(III) in the initiation of lipid peroxidation by iron(II) and hydrogen peroxide. Journal of Biological Chemistry 1987; 262: 1098–1104
   PubMed Web of Science ®Google Scholar
• Minotti G., Aust S.D. Redox cycling of iron and lipid peroxidation. Lipids 1992; 27: 219–226
   PubMed Web of Science ®Google Scholar
• Tadolini B., Franconi F. Carvedilol inhibition of lipid peroxidation. A new antioxidative mechanism. Free Radical Research 1998; 29: 377–387
   PubMed Web of Science ®Google Scholar
• Dean R.T., Hunt J.V., Grant A.J., Yamamoto Y., Niki E. Free radical damage to proteins: the influence of the relative localization of radical generation, antioxidants, and target proteins. Free Radical Biology and Medicine 1991; 11: 161–168
   PubMed Web of Science ®Google Scholar
• Wardlaw J.R., Sawyer W.H., Ghiggino K.P. Vertical fluctuations of phospholipid acyl chains in bilayers. FEBS Letters 1987; 223: 20–24
   PubMedGoogle Scholar
• Bertelli A.A.E., Giovannini L., Stradi R., Bertelli A., Tillement J.P. Plasma, urine and tissue levels of trans- and cis-resveratrol (3,4′,5-trihydroxystilbene) after short-term or prolonged administration of red wine to rats. International Journal of Tissue Reactivity 1996; 18: 67–71
   PubMedGoogle Scholar
• Engelhart K., Jentzsch A.M., Furst P., Biesalski H.K. Short-term parenteral application of alphatocopherol leads to increased concentration in plasma and tissues of the rat. Free Radical Research 1998; 29: 421–426
   PubMed Web of Science ®Google Scholar
• Farrell P.M. Deficiency states, pharmacological effects and nutrient requirements. Vitamin E. A Comprehensive Treatise, L.J. Machlin. M. Dekker Inc., New York and Basel 1980; 520–620, In
   Google Scholar
• Rader D.J., Brewer H.B., Jr. Abetalipoproteinemia. New insights into lipoprotein assembly and vitamin E metabolism from a rare genetic disease. Journal of American Medical Association 1993; 270: 865–869
   PubMed Web of Science ®Google Scholar